Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
CELC - Celcuity Inc - Stock Price Chart
TickerCELC [NASD, RUT]
CompanyCelcuity Inc
CountryUSA
IndustryBiotechnology
Market Cap510.25MEPS (ttm)-3.03
P/E-EPS this Y-19.04%
Forward P/E-EPS next Y2.25%
PEG-EPS past 5Y-31.53%
P/S-EPS next 5Y31.69%
P/B5.88EPS Q/Q-33.64%
Dividend-Sales Q/Q-
Insider Own18.54%Inst Own76.59%
Insider Trans0.00%Inst Trans2.86%
Short Float7.92%EarningsMay 14/a
Analyst Recom1.00Target Price28.71
Avg Volume223.84K52W Range7.57 - 19.77
Jul-01-25Resumed Stifel Buy $30
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Furcht LeoDirectorDec 02 '24Option Exercise3.6025090010,750Dec 03 06:11 PM
Buller Richard EDirectorOct 23 '24Sale16.253505,6886,681Oct 25 04:15 PM
Buller Richard EDirectorAug 23 '24Sale16.953505,9327,031Aug 27 04:13 PM
Buller Richard EDirectorAug 23 '24Proposed Sale16.9570011,865Aug 23 10:27 AM
SID - Companhia Siderurgica Nacional ADR - Stock Price Chart
TickerSID [NYSE]
CompanyCompanhia Siderurgica Nacional ADR
CountryBrazil
IndustrySteel
Market Cap2.00BEPS (ttm)-0.35
P/E-EPS this Y84.14%
Forward P/E9.28EPS next Y615.11%
PEG-EPS past 5Y-
P/S0.25EPS next 5Y-
P/B0.88EPS Q/Q11.14%
Dividend2.29%Sales Q/Q-4.91%
Insider Own0.01%Inst Own2.41%
Insider Trans0.00%Inst Trans2.91%
Short Float0.62%EarningsMay 09/b
Analyst Recom3.45Target Price1.83
Avg Volume3.04M52W Range1.27 - 2.50
Companhia Siderurgica Nacional engages in the production and sale of integrated steel. It operates through the following segments: Steel, Mining, Cement, Logistics, and Energy. The Steel segment offers flat steel, long steel, metallic containers, and galvanized steel. The Mining segment encompasses the activities of iron ore and tin mining. The Cement segment produces CP-III type cement as well as explores limestone and dolomite. The Logistics segment manages railways and port terminals comprise the logistics system that integrates mining, steelmaking, and cement units. The Energy segment consists of generation plants such as electricity to power rolling mills, production lines, hot metal processing, coking plants, and auxiliary units. The company was founded in 1913 and is headquartered in Sao Paulo, Brazil.
CIFR - Cipher Mining Inc - Stock Price Chart
TickerCIFR [NASD, RUT]
CompanyCipher Mining Inc
CountryUSA
IndustryCapital Markets
Market Cap1.77BEPS (ttm)-0.37
P/E-EPS this Y-75.62%
Forward P/E-EPS next Y76.08%
PEG-EPS past 5Y-129.25%
P/S11.65EPS next 5Y-
P/B2.67EPS Q/Q-182.46%
Dividend-Sales Q/Q1.71%
Insider Own33.06%Inst Own41.37%
Insider Trans0.00%Inst Trans18.62%
Short Float19.94%EarningsMay 06/b
Analyst Recom1.17Target Price6.75
Avg Volume22.48M52W Range1.86 - 7.99
Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
V3 Holding Ltd10% OwnerJul 01 '25Proposed Sale4.86500,0002,428,700Jul 01 05:05 PM
GROSSMAN CARY MDirectorFeb 26 '25Proposed Sale4.0650,000202,775Feb 26 03:17 PM
Bitfury Top HoldCo B.V.10% OwnerDec 17 '24Sale7.553,12023,55697,567,437Dec 19 04:18 PM
Bitfury Top HoldCo B.V.10% OwnerDec 16 '24Sale7.23300,0002,169,00097,820,557Dec 18 04:25 PM
Bitfury Top HoldCo B.V.10% OwnerDec 17 '24Sale7.42250,0001,855,00097,570,557Dec 18 04:25 PM
VYGR - Voyager Therapeutics Inc - Stock Price Chart
TickerVYGR [NASD, RUT]
CompanyVoyager Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap186.21MEPS (ttm)-1.46
P/E-EPS this Y-74.92%
Forward P/E-EPS next Y14.33%
PEG-EPS past 5Y1.48%
P/S2.78EPS next 5Y-12.46%
P/B0.68EPS Q/Q-167.94%
Dividend-Sales Q/Q-66.83%
Insider Own18.69%Inst Own62.86%
Insider Trans-0.74%Inst Trans0.19%
Short Float8.71%EarningsMay 06/a
Analyst Recom1.09Target Price15.78
Avg Volume561.82K52W Range2.64 - 9.55
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ferguson TobyChief Medical OfficerApr 02 '25Sale3.4310,08634,595157,914Apr 04 04:10 PM
Sandrock AlfredPresident and CEOApr 02 '25Sale3.4310,88537,336430,931Apr 04 04:08 PM
Sandrock AlfredOfficerApr 02 '25Proposed Sale3.4310,88537,369Apr 02 04:19 PM
Ferguson TobyOfficerApr 02 '25Proposed Sale3.4310,08634,624Apr 02 04:11 PM
Carter Todd AlfredChief Scientific OfficerFeb 20 '25Sale4.263,30514,07977,718Feb 24 04:21 PM
HIVE - HIVE Digital Technologies Ltd - Stock Price Chart
TickerHIVE [NASD]
CompanyHIVE Digital Technologies Ltd
CountryUSA
IndustryCapital Markets
Market Cap449.29MEPS (ttm)-0.37
P/E-EPS this Y-1150.00%
Forward P/E5.34EPS next Y267.35%
PEG-EPS past 5Y1.63%
P/S3.90EPS next 5Y-
P/B0.82EPS Q/Q-942.94%
Dividend-Sales Q/Q-15.51%
Insider Own0.43%Inst Own14.76%
Insider Trans0.00%Inst Trans-6.48%
Short Float4.17%EarningsJun 26/b
Analyst Recom1.00Target Price6.56
Avg Volume14.05M52W Range1.26 - 5.54
Jun-26-25 06:00AM RETRANSMISSION: HIVE Achieves FY2025 Total Revenue of $115.3 Million and $56.2 Million Adjusted EBITDA with 1,414 Bitcoin Mined and 3x Growth in AI GPU Revenue (Newsfile)
02:10AM HIVE Achieves FY2025 Total Revenue of $115.3 Million and $56.2 Million Adjusted EBITDA with 1,414 Bitcoin Mined and 3x Growth in AI GPU Revenue (Newsfile)
Jun-25-25 09:17AM What To Expect From HIVE Digital Technologies Ltd (TSXV:HIVE) Q4 2025 Earnings (GuruFocus.com)
Jun-24-25 06:00AM RETRANSMISSION: BUZZ HPC Launches Another NVIDIA Hopper GPU Cluster, as One of Canada's Leading Sovereign AI Clouds (Newsfile) +10.78%
01:00AM BUZZ HPC Launches Another NVIDIA Hopper GPU Cluster, as One of Canada's Leading Sovereign AI Clouds (Newsfile)
Jun-23-25 06:00AM RETRANSMISSION: HIVE Digital Technologies Announces the Acquisition of 7.2 MW Toronto Data Center for Future BUZZ HPC and Sovereign AI Development (Newsfile)
01:28AM HIVE Digital Technologies Announces the Acquisition of 7.2 MW Toronto Data Center for Future BUZZ HPC and Sovereign AI Development (Newsfile)
Jun-20-25 09:33AM Cantor Fitzgerald Remains Bullish on Hive Digital (HIVE) With a $5 PT (Insider Monkey)
06:00AM RETRANSMISSION: HIVE Digital Technologies Surpasses 11 EH/s Bitcoin Hashrate Milestone as 100 MW Phase 1 in Paraguay Completed Ahead of Schedule - Company on Track to Reach 25 EH/s by Thanksgiving (Newsfile)
01:00AM HIVE Digital Technologies Surpasses 11 EH/s Bitcoin Hashrate Milestone as 100 MW Phase 1 in Paraguay Completed Ahead of Schedule - Company on Track to Reach 25 EH/s by Thanksgiving (Newsfile)
HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. It operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. The firm owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. Its project includes Iceland Cryptocurrency Mining. HIVE Digital Technologies was founded on June 24, 1987 and is headquartered in San Antonio, TX.
INO - Inovio Pharmaceuticals Inc - Stock Price Chart
TickerINO [NASD, RUT]
CompanyInovio Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap80.69MEPS (ttm)-3.19
P/E-EPS this Y47.65%
Forward P/E-EPS next Y13.35%
PEG-EPS past 5Y22.92%
P/S288.17EPS next 5Y39.23%
P/B1.57EPS Q/Q61.02%
Dividend-Sales Q/Q-
Insider Own0.79%Inst Own37.18%
Insider Trans0.00%Inst Trans2.54%
Short Float17.75%EarningsMay 13/a
Analyst Recom1.80Target Price8.00
Avg Volume688.70K52W Range1.42 - 12.33
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
SBET - SharpLink Gaming Inc - Stock Price Chart
TickerSBET [NASD]
CompanySharpLink Gaming Inc
CountryUSA
IndustryGambling
Market Cap626.22MEPS (ttm)-9.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-19.77%
P/S182.57EPS next 5Y-
P/B2.78EPS Q/Q73.66%
Dividend-Sales Q/Q-24.00%
Insider Own0.32%Inst Own7.93%
Insider Trans35.50%Inst Trans6.70%
Short Float8.55%EarningsMar 17/b
Analyst Recom-Target Price-
Avg Volume5.79M52W Range2.26 - 124.12
SharpLink Gaming, Inc. is an online performance-based marketing company, which engages in the provision of online platform facilitating sports betting. It connects sports fans, leagues, and sports websites to relevant and timely sports betting content. The company was founded by Robert Phythian in 2019 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Phythian RobChief Executive OfficerMay 30 '25Buy6.7244,640299,98157,349Jun 02 07:04 PM
DeLucia Robert MichaelChief Financial OfficerMay 30 '25Buy6.727,44049,99714,107Jun 02 06:59 PM
Bernhard LeslieDirectorMar 31 '25Option Exercise0.0016,667073,334Apr 02 04:30 PM
MCKENZIE OBIEDirectorMar 31 '25Option Exercise0.0016,667073,334Apr 02 04:30 PM
GUTKOWSKI ROBERT MDirectorMar 31 '25Option Exercise0.0016,667073,334Apr 02 04:30 PM
RZLT - Rezolute Inc - Stock Price Chart
TickerRZLT [NASD]
CompanyRezolute Inc
CountryUSA
IndustryBiotechnology
Market Cap413.45MEPS (ttm)-1.16
P/E-EPS this Y30.96%
Forward P/E-EPS next Y-2.19%
PEG-EPS past 5Y40.87%
P/S-EPS next 5Y12.97%
P/B3.49EPS Q/Q19.52%
Dividend-Sales Q/Q-
Insider Own19.55%Inst Own49.40%
Insider Trans17.60%Inst Trans4.03%
Short Float7.36%EarningsMay 13/a
Analyst Recom1.00Target Price13.11
Avg Volume1.29M52W Range2.21 - 6.19
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its clinical assets include Ersodetug, a potential treatment for hypoglycemia caused by multiple forms of hyperinsulinism, and RZ402, an oral plasma kallikrein inhibitor and potential therapy for the chronic treatment of diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBERTS BRIAN KENNETHChief Medical OfficerJun 25 '25Buy4.382,50010,93915,500Jun 26 09:07 AM
Evans DaronCFOJun 24 '25Buy4.055,00020,250268,900Jun 24 12:41 PM
Kim Young-JinDirectorJun 13 '25Buy3.251,230,7693,999,9998,423,386Jun 23 09:38 AM
KREHER NERISSADirectorJun 13 '25Buy3.253,0769,99737,576Jun 23 09:12 AM
Hogenhuis WladimirDirectorMar 31 '25Buy2.926,75819,73384,025Apr 01 03:52 PM
ENGN - enGene Holdings Inc - Stock Price Chart
TickerENGN [NASD]
CompanyenGene Holdings Inc
CountryCanada
IndustryBiotechnology
Market Cap199.31MEPS (ttm)-1.65
P/E-EPS this Y-37.62%
Forward P/E-EPS next Y-11.86%
PEG-EPS past 5Y-
P/S-EPS next 5Y-9.68%
P/B0.88EPS Q/Q-33.19%
Dividend-Sales Q/Q-
Insider Own57.16%Inst Own40.70%
Insider Trans0.00%Inst Trans-27.36%
Short Float0.23%EarningsJun 12/b
Analyst Recom1.10Target Price23.00
Avg Volume80.47K52W Range2.65 - 11.00
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Forbion Growth Opportunities F10% OwnerOct 30 '24Buy8.90561,7974,999,9933,032,430Nov 01 04:15 PM
Forbion Growth Opportunities F10% OwnerSep 30 '24Buy6.34341,3322,163,3622,400,791Oct 18 04:15 PM
Forbion Growth Opportunities F10% OwnerSep 27 '24Buy5.9741,639248,6992,059,459Oct 18 04:15 PM
Forbion Growth Opportunities F10% OwnerOct 01 '24Buy6.4435,279227,1582,436,070Oct 18 04:15 PM
Forbion Growth Opportunities F10% OwnerOct 07 '24Buy6.5511,84477,5312,469,833Oct 18 04:15 PM
HOOD - Robinhood Markets Inc - Stock Price Chart
TickerHOOD [NASD]
CompanyRobinhood Markets Inc
CountryUSA
IndustryCapital Markets
Market Cap87.78BEPS (ttm)1.75
P/E56.77EPS this Y-18.31%
Forward P/E65.59EPS next Y19.00%
PEG8.82EPS past 5Y-
P/S26.78EPS next 5Y6.44%
P/B11.06EPS Q/Q105.96%
Dividend-Sales Q/Q49.52%
Insider Own16.40%Inst Own57.22%
Insider Trans-4.00%Inst Trans-4.09%
Short Float4.08%EarningsApr 30/a
Analyst Recom1.79Target Price75.67
Avg Volume44.52M52W Range13.98 - 99.18
Jul-01-25Reiterated Cantor Fitzgerald Overweight $89 → $100
Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VLADIMIR TENEVDirectorJul 01 '25Proposed Sale93.63750,00070,222,500Jul 01 04:27 PM
JASON WARNICKOfficerJun 30 '25Proposed Sale83.03175,00014,530,250Jun 30 04:21 PM
Quirk Steven M.Chief Brokerage OfficerJun 25 '25Sale84.9692,2577,838,413136,364Jun 27 05:40 PM
Warnick JasonChief Financial OfficerJun 25 '25Sale83.63350,00029,270,360598,797Jun 27 05:40 PM
JASON WARNICKOfficerJun 25 '25Proposed Sale82.01350,00028,703,500Jun 25 04:25 PM
11011121314151617181920